Regeneron Pharmaceuticals Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals

REGN 642.25

-1.5%

Nov 3 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: A.J. Mullen	9/25/2024 11:20:05 AM
	of 3557

Regeneron Dives As Amgen Tees Up Its Rival To Moneymaking Machine Eylea investors.com The market's reaction is greater than I expected. REGN has approval for a higher dose. Presumably it's viable for competitors to seek approval for a higher dose. Is that so? How long would that take?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next